Facebook to tackle content with misleading health claims
The logo of Facebook is pictured during the Viva Tech start-up and technology summit in Paris, France, May 25, 2018. REUTERS/Charles Platiau
(Reuters) - Facebook Inc said on Tuesday it was taking steps to reduce promotion of products based on misleading health-related claims.
In a blog post https://newsroom.fb.com/news/2019/07/addressing-sensational-health-claims, the social media company said it had made two updates last month to reduce posts with exaggerated or sensational health claims.
Facebook said it will take actions to reduce posts making assertions about a "miracle cure", and against the ones aimed to promote products or services on health-related claims, such as a pill for weight loss.
The company and its peers around the world are under growing pressure to rid their platforms of fake news and misinformation, and the spread of misleading health claims were highlighted as a concern in some recent media reports.
The Wall Street Journal had earlier reported that Facebook and YouTube were filled with "harmful information" about health treatments.
"We know that people don't like posts that are sensational or spammy, and misleading health content is particularly bad for our community," Facebook product manager Travis Yeh said.
The update will not have a major impact on users' news feed, Facebook said.
(Reporting by Sayanti Chakraborty in Bengaluru; Editing by Anil D'Silva and Shounak Dasgupta)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger to cut over one-third of corporate workforce in major restructuring
- eBay named Morgan Stanley top pick on live commerce flywheel; stock surges
- C3.ai rallies after Northland upgrades stock on enterprise AI platform launch
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share